We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Genetic Mutation Causes Lethal Condition in Infants

By LabMedica International staff writers
Posted on 05 Aug 2015
Print article
Ion Torrent Proton Sequencer
Ion Torrent Proton Sequencer (Photo courtesy of Thermo Fisher (Life Technologies))
Protein losing enteropathy (PLE) is a condition of the gastrointestinal tract that results in loss of protein from the body, and often leads to severe abdominal swelling, malnutrition and early death in affected infants.

Whole-exome sequencing has been used to identify a nonsense mutation in the plasmalemma vesicle-associated protein gene that results in a distinct severe form of PLE characterized by hyperproteinemia, hypoalbuminemia, and hypertriglyceridemia.

Scientists at the Hospital for Sick Children (Toronto, ON, Canada) obtained samples from a patient with the PLVAP p.Arg358* mutation on two occasions during endoscopic investigation for severe PLE. Control samples from the duodenum or colon were obtained from patients who were undergoing evaluation of gastrointestinal symptoms, among whom the endoscopic, histologic, and follow-up clinical impressions were normal.

Whole-exome sequencing was performed and the exome library preparation was performed using the Ion Torrent AmpliSeq RDY Exome Kit (Life Technologies; Carlsbad, CA, USA) and DNA quantified by Qubit DNA HS or BR assay (Life Technologies). The library was purified with Agencourt Ampure XT beads (Agencourt Bioscience; Beverly, MA, USA). Libraries were quantified by quantitative polymerase chain reaction (PCR) and sequenced on an Ion Torrent Proton Sequencer using a PI chip V2. The investigators used a variety of techniques for their study including flow cytometry read on a FACSCalibur (BD Biosciences; San Jose, CA, USA), confocal microscopy, histology and immunofluorescence.

The defect caused by mutations in PLVAP was due to increased leakage from small blood vessels rather than active loss from the cells lining the intestines. This finding is different from most cases of enteropathy, including the Microvillus Inclusion Disease and Congenital Tufting Enteropathy, which affect young children. In these latter conditions, genetic abnormalities cause cellular abnormalities primarily affecting intestinal epithelial tissue structure and function.

Abdul Elkadri, the lead study author, said, “These findings come at a critical time in medical science; the recent promise of gene therapy may make targeted correction of PLVAP mutations possible. In the meantime, we can use these findings to develop more rapid diagnostic strategies to screen infants for this genetic mutation and prevent severe complications at an early stage of the disease.” The study was published in the July 2015 issue of the journal Cellular and Molecular Gastroenterology and Hepatology.

Related Links:

Hospital for Sick Children
Life Technologies
Agencourt Bioscience



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.